Skip to content

Mpm Bioventures 2018, L.P., 10% owner at Entrada Therapeutics, sold TRDA on Sep 8, 2026

Data as of Oct 16

▼ SELL$1.4M192,500 shares at $7.41Mpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.
Watch TRDA
Traded
Sep 8, 2026
Disclosed
Sep 9, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Mpm Bioventures 2018, L.P., 10% owner at Entrada Therapeutics, sold TRDA on Sep 8, 2026TRADEDDISCLOSED
TRDASimilar stocks (XLV — its sector index fund), rebased to TRDA's price on the disclosure day
TRDA since disclosure
−38.5%
after the sale
Similar stocks (XLV) since disclosure
+6.1%
XLV — its sector index fund

Change in closing price from Sep 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  2. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  3. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  4. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  5. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  7. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  8. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late

See every trade on TRDA →